Laurie Saloman is a seasoned medical journalist who has written extensively about HIV, influenza, Zika, Covid-19, cancer, endocrine disorders, mental illness, and other infectious and non-infectious diseases. Her work has appeared in Contagion, The American Journal of Managed Care, Pfizer’s Breakthroughs.com, Health After 50, and the journal of the Emergency Nurses Association, among others. A member of the Association of Health Care Journalists and the American Society of Journalists and Authors, Laurie lives in New Jersey with her family. You can reach her on Twitter: @LaurieSaloman
Older Adults with Gastrointestinal Infections Display Fewer Symptoms
January 18th 2019While young people with enteric infections have the lion’s share of symptoms, the elderly suffer higher rates of complications and hospitalizations from these illnesses. Arriving at a correct, timely diagnosis for this cohort of patients is key.
Read More
Atlanta HIV Rates Highlight the Need for Coordinated Effort in US Cities
December 20th 2018HIV stubbornly retains a foothold in major US cities, particularly those in the South. A lack of synergistic efforts among public health agencies can compound the problem, as can embedded attitudes and stigma.
Read More
HIV Impacts Neurocognition in Resource-Limited Settings
September 27th 2018Despite big advances in the field of HIV treatment, including streamlined drug regimens that help infected people achieve normal or near-normal lifespans, living with HIV often means dealing with neurocognitive impairment of some kind.
Read More
Epidemiological Trends in Pertussis Reveal Limitations of Acellular Vaccines
September 20th 2018An examination of 17 years of data reveals that children who received the combination acellular vaccine Tdap were vulnerable to pertussis much earlier than expected. Researchers are hopeful that new vaccines will extend protection against the disease.
Read More
Gram-Negative Bacteria in Pneumonia Patients Demands Targeted Therapies
August 2nd 2018Gram-negative organisms are showing up at higher rates in seriously ill pneumonia patients. What are the best antibiotics to prescribe, given the real risk of death and the need to avoid contributing to drug resistance?
Read More